India Pesticides Ltd Q2 FY26 – When Agrochemistry Meets Bollywood Drama: Revenue Grows 26%, Profit Climbs 21%, and Inventory Still Refuses to Leave Home
1. At a Glance
Ladies and gentlemen, welcome to another episode of Crop Story with a Twist. India Pesticides Limited (IPL) – the agrochemical wizard from Lucknow – has reported a solid Q2 FY26 performance with revenue touching ₹289.63 crore and PAT clocking ₹32.04 crore. That’s a spicy 26.6% YoY jump in sales and a 21% pop in profits. EPS for the quarter stood at ₹2.78, taking the annualized number to ₹11.12. At ₹188 per share, the market is valuing this pesticide power player at ₹2,171 crore – roughly the cost of two Bollywood biopics and an IPL team sponsorship.
Operating margins remained at 17%, proving that efficiency is not a weed that needs uprooting. With ROCE of 13% and ROE of 9.7%, the company isn’t setting the field on fire, but it’s definitely growing something better than grass. The stock’s P/E of 20.3 is modest compared to its pesticide peers, who seem to charge extra just for smelling like chlorpyrifos.
After a year filled with new capacity, anti-dumping duties, and a management shuffle, India Pesticides has somehow managed to look stable in an industry known for volatility. But behind the green sheen, a lot of interesting chemistry is brewing – quite literally.
2. Introduction
If you thought only Bollywood sequels reused formulas, welcome to the world of agrochemicals. India Pesticides Ltd, born in 1984, has been serving India’s farmers and the world’s pest control warriors for four decades. From the land of kebabs and chemistry (Lucknow), this company manufactures crop protection chemicals that ensure pests die on time, but balance sheets live longer.
In FY24, the firm battled high inventories, delayed MNC orders, and working capital cycles that looked like never-ending soap operas. Yet, in Q2 FY26, IPL seems to have found its groove again. Revenue climbed 26%, and net profit followed, powered by increased demand for its technicals and APIs – the real cash crops in its portfolio.
The firm is among the top five global manufacturers for fungicides like Folpet and Captan, and the only Indian player to make some thiocarbamate herbicides. You could call it India’s Breaking Bad—but without the meth, and with more methyl chlorophenyl.
Its mix of agrochemicals and pharma APIs makes it a hybrid of a pesticide company and a skin-care lab — it kills fungi on crops and cures them on humans. Truly a diversified portfolio.
But the market isn’t entirely convinced. The five-year profit growth is crawling at 3.5%, and the stock has barely moved in a year. So what’s really cooking in Lucknow’s chemical cauldron?
3. Business Model – WTF Do They Even Do?
India Pesticides’ business model is part scientist, part wholesaler, and part patient teacher of chemistry. It operates three divisions:
a) Technicals: This is the crown jewel — comprising fungicides, herbicides, and insecticides that protect crops. Products like Captan and Folpet have made IPL a global name. This segment also feeds exports, which account for 40% of total revenue.
b) Formulations: These are ready-to-use mixtures tailored for specific crops. Farmers get the “just spray and chill” experience.
c) APIs: Because why stop at plants? The company also manufactures Active Pharmaceutical Ingredients — particularly antifungal and anti-scabies drugs. Basically, from “fungus on wheat” to “fungus on feet,” IPL has you covered.
Two major plants — at Dewa Road and Sandila in Uttar Pradesh — handle a combined 24,200 MTPA of technicals and 6,500 MTPA of formulations. Together, they produce 27 technicals, 207 formulations, and 2 APIs.
Export markets span 25+ countries, with key clients like UPL, Rallis, Sharda Cropchem, Syngenta, and Adama. But top 10 customers still contribute 42% of revenues — a sign that a sneeze from one client can give the company a financial cold.
And while 67% of raw materials are sourced locally (a win for Make in India), the remaining 33% are imported — which means global commodity tantrums can still spoil the party.
4. Financials Overview
Metric
Latest Qtr (Sep’25)
YoY Qtr (Sep’24)
Prev Qtr (Jun’25)
YoY %
QoQ %
Revenue
₹290 Cr
₹229 Cr
₹275 Cr
26.6%
5.4%
EBITDA
₹49 Cr
₹34 Cr
₹46 Cr
44.1%
6.5%
PAT
₹32 Cr
₹26 Cr
₹35 Cr
21.0%
-8.6%
EPS (₹)
2.78
2.30
3.07
21.0%
-9.5%
Annualized EPS = ₹11.12; P/E = 16.9x
Commentary: IPL’s quarterly performance shows that after a patchy FY24, the company is back to growth mode. QoQ dip in PAT is due to seasonal factors (and probably too much fertilizer
